Navigation Links
China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2011
Date:6/10/2011

HONG KONG, June 10, 2011 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced preliminary unaudited financial results for the fourth quarter and fiscal year of 2011, which ended March 31, 2011.

Fourth Quarter of Fiscal 2011 Highlights

  • Revenue in the fourth quarter of fiscal 2011 increased 33.7% to RMB94.7 million ($14.5 million) from RMB70.8 million in the fourth quarter of fiscal 2010.
  • New subscriber sign-ups reached 15,641 during the quarter.
  • Gross profit increased 34.1% to RMB74.7 million ($11.4 million) from RMB55.7 million from the prior year period.
  • Gross margin reached 78.9%, comparing to 78.7% for the prior year period.
  • Operating income increased 46.3% to RMB36.4 million ($5.6 million) from RMB24.9 million in the prior year period.
  • Net income attributable to shareholders increased 62.8% to RMB26.3 million ($4.0 million) from RMB16.1 million in the prior year period.

  • Fiscal Year 2011 Highlights

  • Revenue for fiscal 2011 increased 29.8% to RMB339.5 million ($51.9 million) from RMB261.5 million last year.
  • New subscriber sign-ups grew 24.9% to 56,518 from 45,252 in fiscal 2010.
  • Gross profit increased 33.9% to RMB262.2 million ($40.0 million) from RMB195.8 million in fiscal 2010.
  • Gross margin continued to expand to 77.2% from 74.9% in fiscal 2010.
  • Operating income increased 27.4% to RMB123.8 million ($18.9 million) from RMB97.2 million in fiscal 2010.
  • Net income attributable to shareholders increased 86.5% to RMB91.7 million ($14.0 million) from RMB49.2 million in fiscal 2010.

  • "We achieved a triumph in the fiscal year of 2011 with impressive operat
    '/>"/>

    SOURCE China Cord Blood Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. Reportlinker Adds Industrial Biotechnology China News 1105 - Annual Subscription
    2. NIST contests in China put next-gen robot technologies to the test
    3. Reportlinker Adds Future of White Biotechnology in China
    4. China Cord Blood Corporation to Report Fourth Quarter and Full Year Fiscal 2011 Financial Results
    5. MicroConstants China Receives Endorsement of OECD GLP Compliance
    6. China Botanic Exhibits All-Natural Products at the 65th PHARMACHINA Fair
    7. Epichem and AR Brown Sign Exclusive Distribution Agreement for Japan, Taiwan, China and South Korea
    8. Reportlinker Adds Industrial Biotechnology China News 1104
    9. China Green Material Technologies, Inc. Announces Change of Auditor to Marcum Bernstein & Pinchuk LLP
    10. ThermoGenesis Announces China Customer Implements Cord Blood Products
    11. Reportlinker Adds China Bio-breeding Industry Report, 2010
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/29/2015)... 29, 2015 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") today ... 2014. Biorem,s complete fiscal 2014 year-end financial statements and MD&A have been ... , 2013 , 2014 , 2013 Revenue ... 19,596 Gross profit 1,326 , 1,703 , 2,231 ... 1,493 , 3,377 , 4,562 Ebitda* 92 ...
    (Date:4/29/2015)... 2015 Cambrex Corporation (NYSE: CBM ) announced ... Friday, May 1, 2015 before the market opens. , ... host a conference call to discuss the financial results. First ... , Friday, May 1, 2015 at 8:30 a.m. Eastern ... U.S.1-719-325-2454 for International  Passcode:  7993632 Dial-in Replay: ...
    (Date:4/29/2015)... The leading Regenerative Veterinary Medicine Company, VetStem ... cell therapy has processed more than 11,000 samples. ... successful treatment for horses with potentially fatal injuries to ... worldwide exclusive license for adipose-derived (fat derived) stem cell ... treated in January 2004. Shortly after, the first dogs ...
    (Date:4/29/2015)... - Northern Biologics Inc., a privately held biotechnology company ... strategic collaboration with Celgene Corporation.  As part of ... upfront cash payment. It will use the funds ... will have the right to receive additional future ... Under the agreement, Northern Biologics ...
    Breaking Biology Technology:Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 2Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 3Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014 4VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples 2Northern Biologics and Celgene Enter Strategic Collaboration 2
    ... predicting and quashing environmental decoherence, a phenomenon that has proven ... the way of quantum computing. The findings based ... and confirmed by experiments at the University of California Santa ... of the journal Nature . Quantum mechanics states ...
    ... July 20, 2011 Regulus Therapeutics Inc ., ... innovative medicines targeting microRNAs, today announced that it has ... GlaxoSmithKline (GSK), triggering a preclinical milestone payment from GSK. ... its microRNA alliance with GSK, which is focused on ...
    ... July 20, 2011 ReSearch Pharmaceutical Services, Inc. ... global Phase II-IV clinical development solutions to the ... following key additions to its Operational and Senior ... Davis, II, as Chief Information Officer and Executive ...
    Cached Biology Technology:Discovery may overcome obstacle for quantum computing 2Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 2Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 3Regulus Therapeutics and GlaxoSmithKline Name a Third Alliance microRNA Target Triggering a Preclinical Milestone Payment 4RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership 2RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership 3
    (Date:4/9/2015)... SAN JOSE, Calif. , April 9, 2015 /PRNewswire/ ... of human interface solutions, announced today that it will ... 2015 on Thursday, April 23, 2015, after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
    (Date:4/2/2015)... Germany , April 2, 2015 ... fingerprint tests DERMALOG by far outperforms the strongest ... always maintaining high accuracy, the system is capable ... Hence, the speed proves up to be ten ... faster than its runner-up performance.      ...
    (Date:4/2/2015)... Fingerprint Cards (FPC) has received ... the distributor World Peace Industrial Group (WPI), part of ... the major part of the shipments will take place ... smartphone manufacturers in China . The ... communicated revenue guidance of + 1 000 MSEK for 2015.  ...
    Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
    ... 26, 2011Magnetic resonance tractography (MRT) is a valuable, ... and, as MRT methods and technologies advance, has ... on brain activity and connectivity. Critical information about ... explored in a forward-looking review article in the ...
    ... Texas at Austin researchers have discovered how to extract and ... objects are from the focus distance, a feat only accomplished ... Like a camera, the human eye has an auto-focusing system, ... humans do not require trial and error to focus an ...
    ... used local anesthetic, may more easily wiggle into a ... compounds that carry a negative charge, a new study ... more complete understanding of the molecular-level mechanisms behind pain-blocking ... use. Most scientists believe that local anesthetics prevent ...
    Cached Biology News:Researchers develop optimal algorithm for determining focus error in eyes and cameras 2
    L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
    ANTI 5-HYDROXYTRYPTOPHAN CONJ....
    PAb to Hu-IFN-Alpha/Beta R2 [(IFNAR2) CD118], Rabbit Serum, neutralizing Binds to but does not neutralize human interferon alpha/beta receptor...
    IMAGEQUANT 100 IQTL, 1 EA. Category: ImageQuant CCD Imagers....
    Biology Products: